ESC TV at #AHA21 - Expert Perspectives on the EMPULSE Trial

(2:19)

EMPULSE Results

(7:10)

ACC 22: Results from the EMPULSE Study - Empagliflozin Proves Beneficial for Patients with HF

(5:36)

AHA 2021 Late-Breaker Discussion: The EMPULSE Trial

(5:9)

EMPULSE: The ‘missing link’ for empagliflozin in heart failure | Adriaan Voors

(5:21)

Quality of life improvement with Empagliflizon - Results from EMPULSE Trial

(7:10)

EMPULSE Trial. EMPAGLIFLOZIN in Acute Heart Failure. AHA2021

(7:24)

ESC TV at HF 2019 - IMPULSE-HF a randomized controlled trial

(1:55)

Empagliflozin in Patients Hospitalized for Acute Heart Failure – EMPULSE trial

(2:9)

La SEC te lleva a AHA21 [IN] ∙ EMPULSE Trial

(8:52)

Recent and Upcoming Diabetes Outcome Trials

(31:31)

SGLT2 Inhibitors in Acute Heart Failure The Earlier The Better DICTATE AHF

(11:50)

Dr. Roman Straßl - empulse PRO+

(17:10)

Heart Failure Guidelines Update What the ESC Got Right

(6:44)

La SEC te lleva a ACC22 [IN] ∙ EMPULSE Trial

(6:41)

Day 2 Highlights | AHA 2021

(10:25)

Empulse Pitch (Long)

(28:2)

EMPULSE: empagliflozina en insuficiencia cardiaca aguda

(1:4:50)